Infusion Pump Market Synopsis

The Infusion Pump Market size is estimated at 14.61 billion USD in 2023 and is expected to reach 21.44 billion USD by 2032, growing at a CAGR of 4.9% during the forecast period (2024-2032).

An infusion pump is a medical device that delivers fluids, such as nutrients and medications, into a patient's body in controlled amounts. Infusion pumps are in widespread use in clinical settings such as hospitals, nursing homes, and in the home

• An infusion pump is a medical device used to deliver fluids, medications, and nutrients directly into a patient's bloodstream. This device is commonly used in hospitals, clinics, and other healthcare facilities for controlled and precise dispensing of fluids and medications. Infusion pumps can be mechanical or electronic and can be programmed to deliver fluids and medications at specific rates and amounts.
• One of the main advantages of infusion pumps is their ability to administer fluids and medications consistently and accurately. This reduces the risk of medication errors and ensures that patients receive the correct dose. In addition, infusion pumps can be used to continuously administer drugs and fluids for long periods of time, making them important tools in the treatment of chronic diseases and intensive care.
• Infusion pumps must be calibrated and maintained regularly to ensure safe and accurate dosing of medications and fluids. There are risks associated with using infusion pumps, such as the risk of infection or incorrect dosing, but these risks can be minimized with proper training and following safety guidelines.

The Infusion Pump Market Trend Analysis

Growing Prevalence of Chronic Diseases

• Increase in chronic diseases is a major factor in the growth of the infusion pump market. Infusion pumps are used to deliver medications, fluids, and other substances directly into a patient's bloodstream, making them an important tool in the treatment of many chronic conditions. Chronic diseases such as diabetes, cancer, and cardiovascular disease are becoming more common worldwide. As a result, the demand for infusion pumps is increasing.
• Apart from the increase in the prevalence of chronic diseases, the proliferation of portable infusion pumps, technological advancements in the design and functionality of infusion pumps, and the growing demand for home healthcare services are also accelerating the growth of the infusion pump market.
• An increase in the incidence of chronic diseases, the rapid growth of the elderly population, the number of ambulatory infusion pumps, and the number of people performing surgical procedures. Intravenous infusion pumps are mostly used to administer critical fluids containing high-risk medications. Most infusion pumps are equipped with safety features and built-in alarms that alert the user and activate them in time of a problem. Many diseases, such as immunodeficiency, cancer, and heart failure, cannot be treated with oral medications and require infusion therapy.

Growing Focus on Emerging Markets & Growing Adoption of Specialty Infusion

• Emerging markets such as Asia Pacific and Latin America are experiencing rapid economic growth and expanding healthcare systems, increasing the demand for infusion pumps. With the improvement of healthcare infrastructure and the availability of medical services in these regions, the demand for infusion pumps is expected to increase significantly.
• In addition, the introduction of specialized infusion systems is another opportunity in the infusion pump market. Specialty infusion systems are designed to deliver specific treatments, such as chemotherapy or pain relief, and are becoming increasingly popular in the healthcare industry. These systems require special pumps that can deliver precise doses of medication over long periods of time, which is what happens when infusion pumps kick in.
• Technological advances in infusion pump design, such as wireless communication and the integration of intelligent infusion systems, are also creating opportunities for the market. These advances allow healthcare providers to monitor and adjust infusion rates remotely, which can improve patient safety and treatment outcomes.

Segmentation Analysis of The Infusion Pump Market

Infusion Pump Market segments cover the Type, Application, and End User. By Type, the Volumetric Infusion Pump segment is Anticipated to Dominate the Market Over the Forecast period.

• Volumetric infusion pumps have a wide range of applications in disease treatment and parenteral nutrition, due to which the volumetric infusion pump has the highest market value compared to other pumps. The safety, precision, and simplicity of the pumps are the reason for the high demand for these pumps.
• The volumetric infusion pump segment holds a major share of the intravenous infusion pump market and is expected to show a similar trend during the forecast period. The growing trend to adopt technologically advanced volumetric infusion pumps with features such as electronic health record (EHR) integration, built-in security systems, drug libraries, etc. is likely to fuel the market growth.
• Volumetric infusion pumps have medication banks, also known as dosage error reduction systems or dosage error reduction programs (DERS), designed to reduce medication administration errors. Thus, such advancements in IV infusion pumps will boost market growth during the forecast period.

Regional Analysis of The Infusion Pump Market

North America is Expected to Dominate the Market Over the Forecast period.

• North America is expected to hold a significant market share in the intravenous infusion pumps market due to the rise in chronic diseases, the growing population, and favorable reimbursement policies in the region.
• Furthermore, adopting new technologically advanced products for regular treatment of chronic disease conditions, awareness pertaining to advance intravenous infusion pumps and the presence of well-established healthcare infrastructure are also fuelling the growth of the overall regional market to a large extent.
• Additionally, initiatives and recommendations by government and private institutions for home care infusions are fuelling the growth of the market in the studied region. For example, according to a 2022 press release from the National Home Infusion Association, several health systems, hospitals, and group purchasing organizations from all 50 states are calling on Congress to address Medicare beneficiaries' access to home infusion therapy and pass legislation to improve access. for home care. based treatment. Thus, such steps will promote the adoption of home care IV infusion systems and thereby increase the growth of the market.

Covid-19 Impact Analysis on Infusion Pump Market

As COVID-19 patients began to flood hospital ICUs, infusion pump supplies quickly dwindled. A large number of orders were sent to suppliers, pressuring them to produce more. The COVID-19 epidemic has strained healthcare infrastructure worldwide, as most eligible healthcare services have been delayed. However, the demand for intravenous infusion pumps such as insulin infusion pumps and volumetric infusion pumps has increased. The majority of patients suffering from chronic diseases received treatment away from home to avoid the risk of spreading the disease and to simplify health services. An Innovation that Increases Drug Mortality and Patient Risk, when the IV tubing system was expanded. The demand for infusion pumps increases. In COVID-19 patients began to flood hospital ICUs, and infusion pump stocks quickly decreased. A rush of orders was sent to suppliers, putting pressure on them to manufacture more. Hence, there were more demand for Infusion pumps was recorded during COVID 19

Top Key Players Covered in The Infusion Pump Market

• B. Braun Melsungen AG (Germany)
• Becton, Dickinson, and Company (U.S.)
• IRadimed Corporation (U.S.)
• Baxter International Inc. (U.S.)
• ICU Medical, Inc. (U.S.)
• Tandem Diabetes Care, Inc. (U.S.)
• ICU Medical, Inc. (U.S.)
• Medtronic (Ireland)
• Smith Medical (U.S.)
• Terumo Corporation (Japan)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Fresenius SE & Co. KGaA (Germany)
• Mindray (India), and Other Major Players

Key Industry Developments in the Infusion Pump Market

• In July 2023, Fresenius Kabi, a German pharmaceutical and medical device company, acquired Iventech, Inc., a US-based developer of advanced ambulatory infusion pumps, for an undisclosed amount. This acquisition gives Fresenius Kabi access to Iventech's innovative pump technology and expands its reach in the home healthcare market.
• In February 2023, Baxter International, a leading medical device company, acquired Medela AG, a Swiss manufacturer of breast pumps and other lactation products, for approximately $1.6 billion. This acquisition strengthens Baxter's position in the maternal-infant healthcare market and expands its infusion pump offerings for mothers requiring additional lactation support.
• In December 2023, BD announced its intention to acquire C. R. Bard, Inc., a US-based medical device company with a strong presence in the infusion pump market, for $24 billion. This acquisition, if approved, would create a global leader in the medical device industry and significantly consolidate the infusion pump market landscape.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application
 3.3 By End User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Infusion Pump Market by Type
 5.1 Infusion Pump Market Overview Snapshot and Growth Engine
 5.2 Infusion Pump Market Overview
 5.3 Volumetric Infusion Pumps
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Volumetric Infusion Pumps: Geographic Segmentation
 5.4 Syringe Infusion Pumps
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Syringe Infusion Pumps: Geographic Segmentation
 5.5 Patient Controlled Analgesia Infusion Pumps
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Patient Controlled Analgesia Infusion Pumps: Geographic Segmentation

Chapter 6: Infusion Pump Market by Application
 6.1 Infusion Pump Market Overview Snapshot and Growth Engine
 6.2 Infusion Pump Market Overview
 6.3 Oncology
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Oncology: Geographic Segmentation
 6.4 Parenteral Nutrition
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Parenteral Nutrition: Geographic Segmentation
 6.5 Pain Management
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Pain Management: Geographic Segmentation
 6.6 Others
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Others: Geographic Segmentation

Chapter 7: Infusion Pump Market by End User
 7.1 Infusion Pump Market Overview Snapshot and Growth Engine
 7.2 Infusion Pump Market Overview
 7.3 Hospitals & Clinics
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals & Clinics: Geographic Segmentation
 7.4 Home Healthcare
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Home Healthcare: Geographic Segmentation
 7.5 Others
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Others: Geographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Infusion Pump Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Infusion Pump Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Infusion Pump Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 B. BRAUN MELSUNGEN AG (GERMANY)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 BECTON
 8.4 DICKINSON
 8.5 & COMPANY (U.S.)
 8.6 IRADIMED CORPORATION (U.S.)
 8.7 BAXTER INTERNATIONAL INC. (U.S.)
 8.8 ICU MEDICAL INC. (U.S.)
 8.9 TANDEM DIABETES CARE INC. (U.S.)
 8.10 ICU MEDICAL INC. (U.S.)
 8.11 MEDTRONIC (IRELAND)
 8.12 SMITH MEDICAL (U.S.)
 8.13 TERUMO CORPORATION (JAPAN)
 8.14 F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND)
 8.15 FRESENIUS SE & CO. KGAA (GERMANY)
 8.16 MINDRAY (INDIA)
 8.17 OTHER MAJOR PLAYERS

Chapter 9: Global Infusion Pump Market Analysis, Insights and Forecast, 2017-2032
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 Volumetric Infusion Pumps
  9.2.2 Syringe Infusion Pumps
  9.2.3 Patient Controlled Analgesia Infusion Pumps
 9.3 Historic and Forecasted Market Size By Application
  9.3.1 Oncology
  9.3.2 Parenteral Nutrition
  9.3.3 Pain Management
  9.3.4 Others
 9.4 Historic and Forecasted Market Size By End User
  9.4.1 Hospitals & Clinics
  9.4.2 Home Healthcare
  9.4.3 Others

Chapter 10: North America Infusion Pump Market Analysis, Insights and Forecast, 2017-2032
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Volumetric Infusion Pumps
  10.4.2 Syringe Infusion Pumps
  10.4.3 Patient Controlled Analgesia Infusion Pumps
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Oncology
  10.5.2 Parenteral Nutrition
  10.5.3 Pain Management
  10.5.4 Others
 10.6 Historic and Forecasted Market Size By End User
  10.6.1 Hospitals & Clinics
  10.6.2 Home Healthcare
  10.6.3 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 US
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Eastern Europe Infusion Pump Market Analysis, Insights and Forecast, 2017-2032
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Volumetric Infusion Pumps
  11.4.2 Syringe Infusion Pumps
  11.4.3 Patient Controlled Analgesia Infusion Pumps
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Oncology
  11.5.2 Parenteral Nutrition
  11.5.3 Pain Management
  11.5.4 Others
 11.6 Historic and Forecasted Market Size By End User
  11.6.1 Hospitals & Clinics
  11.6.2 Home Healthcare
  11.6.3 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Bulgaria
  11.7.2 The Czech Republic
  11.7.3 Hungary
  11.7.4 Poland
  11.7.5 Romania
  11.7.6 Rest of Eastern Europe

Chapter 12: Western Europe Infusion Pump Market Analysis, Insights and Forecast, 2017-2032
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Volumetric Infusion Pumps
  12.4.2 Syringe Infusion Pumps
  12.4.3 Patient Controlled Analgesia Infusion Pumps
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Oncology
  12.5.2 Parenteral Nutrition
  12.5.3 Pain Management
  12.5.4 Others
 12.6 Historic and Forecasted Market Size By End User
  12.6.1 Hospitals & Clinics
  12.6.2 Home Healthcare
  12.6.3 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 Germany
  12.7.2 UK
  12.7.3 France
  12.7.4 Netherlands
  12.7.5 Italy
  12.7.6 Russia
  12.7.7 Spain
  12.7.8 Rest of Western Europe

Chapter 13: Asia Pacific Infusion Pump Market Analysis, Insights and Forecast, 2017-2032
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Volumetric Infusion Pumps
  13.4.2 Syringe Infusion Pumps
  13.4.3 Patient Controlled Analgesia Infusion Pumps
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Oncology
  13.5.2 Parenteral Nutrition
  13.5.3 Pain Management
  13.5.4 Others
 13.6 Historic and Forecasted Market Size By End User
  13.6.1 Hospitals & Clinics
  13.6.2 Home Healthcare
  13.6.3 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 China
  13.7.2 India
  13.7.3 Japan
  13.7.4 South Korea
  13.7.5 Malaysia
  13.7.6 Thailand
  13.7.7 Vietnam
  13.7.8 The Philippines
  13.7.9 Australia
  13.7.10 New Zealand
  13.7.11 Rest of APAC

Chapter 14: Middle East & Africa Infusion Pump Market Analysis, Insights and Forecast, 2017-2032
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Volumetric Infusion Pumps
  14.4.2 Syringe Infusion Pumps
  14.4.3 Patient Controlled Analgesia Infusion Pumps
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Oncology
  14.5.2 Parenteral Nutrition
  14.5.3 Pain Management
  14.5.4 Others
 14.6 Historic and Forecasted Market Size By End User
  14.6.1 Hospitals & Clinics
  14.6.2 Home Healthcare
  14.6.3 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Turkey
  14.7.2 Bahrain
  14.7.3 Kuwait
  14.7.4 Saudi Arabia
  14.7.5 Qatar
  14.7.6 UAE
  14.7.7 Israel
  14.7.8 South Africa

Chapter 15: South America Infusion Pump Market Analysis, Insights and Forecast, 2017-2032
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Type
  15.4.1 Volumetric Infusion Pumps
  15.4.2 Syringe Infusion Pumps
  15.4.3 Patient Controlled Analgesia Infusion Pumps
 15.5 Historic and Forecasted Market Size By Application
  15.5.1 Oncology
  15.5.2 Parenteral Nutrition
  15.5.3 Pain Management
  15.5.4 Others
 15.6 Historic and Forecasted Market Size By End User
  15.6.1 Hospitals & Clinics
  15.6.2 Home Healthcare
  15.6.3 Others
 15.7 Historic and Forecast Market Size by Country
  15.7.1 Brazil
  15.7.2 Argentina
  15.7.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. INFUSION PUMP MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. INFUSION PUMP MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. INFUSION PUMP MARKET COMPETITIVE RIVALRY
TABLE 005. INFUSION PUMP MARKET THREAT OF NEW ENTRANTS
TABLE 006. INFUSION PUMP MARKET THREAT OF SUBSTITUTES
TABLE 007. INFUSION PUMP MARKET BY TYPE
TABLE 008. VOLUMETRIC INFUSION PUMPS MARKET OVERVIEW (2016-2030)
TABLE 009. SYRINGE INFUSION PUMPS MARKET OVERVIEW (2016-2030)
TABLE 010. PATIENT CONTROLLED ANALGESIA INFUSION PUMPS MARKET OVERVIEW (2016-2030)
TABLE 011. INFUSION PUMP MARKET BY APPLICATION
TABLE 012. ONCOLOGY MARKET OVERVIEW (2016-2030)
TABLE 013. PARENTERAL NUTRITION MARKET OVERVIEW (2016-2030)
TABLE 014. PAIN MANAGEMENT MARKET OVERVIEW (2016-2030)
TABLE 015. OTHERS MARKET OVERVIEW (2016-2030)
TABLE 016. INFUSION PUMP MARKET BY END USER
TABLE 017. HOSPITALS & CLINICS MARKET OVERVIEW (2016-2030)
TABLE 018. HOME HEALTHCARE MARKET OVERVIEW (2016-2030)
TABLE 019. OTHERS MARKET OVERVIEW (2016-2030)
TABLE 020. NORTH AMERICA INFUSION PUMP MARKET, BY TYPE (2016-2030)
TABLE 021. NORTH AMERICA INFUSION PUMP MARKET, BY APPLICATION (2016-2030)
TABLE 022. NORTH AMERICA INFUSION PUMP MARKET, BY END USER (2016-2030)
TABLE 023. N INFUSION PUMP MARKET, BY COUNTRY (2016-2030)
TABLE 024. EASTERN EUROPE INFUSION PUMP MARKET, BY TYPE (2016-2030)
TABLE 025. EASTERN EUROPE INFUSION PUMP MARKET, BY APPLICATION (2016-2030)
TABLE 026. EASTERN EUROPE INFUSION PUMP MARKET, BY END USER (2016-2030)
TABLE 027. INFUSION PUMP MARKET, BY COUNTRY (2016-2030)
TABLE 028. WESTERN EUROPE INFUSION PUMP MARKET, BY TYPE (2016-2030)
TABLE 029. WESTERN EUROPE INFUSION PUMP MARKET, BY APPLICATION (2016-2030)
TABLE 030. WESTERN EUROPE INFUSION PUMP MARKET, BY END USER (2016-2030)
TABLE 031. INFUSION PUMP MARKET, BY COUNTRY (2016-2030)
TABLE 032. ASIA PACIFIC INFUSION PUMP MARKET, BY TYPE (2016-2030)
TABLE 033. ASIA PACIFIC INFUSION PUMP MARKET, BY APPLICATION (2016-2030)
TABLE 034. ASIA PACIFIC INFUSION PUMP MARKET, BY END USER (2016-2030)
TABLE 035. INFUSION PUMP MARKET, BY COUNTRY (2016-2030)
TABLE 036. MIDDLE EAST & AFRICA INFUSION PUMP MARKET, BY TYPE (2016-2030)
TABLE 037. MIDDLE EAST & AFRICA INFUSION PUMP MARKET, BY APPLICATION (2016-2030)
TABLE 038. MIDDLE EAST & AFRICA INFUSION PUMP MARKET, BY END USER (2016-2030)
TABLE 039. INFUSION PUMP MARKET, BY COUNTRY (2016-2030)
TABLE 040. SOUTH AMERICA INFUSION PUMP MARKET, BY TYPE (2016-2030)
TABLE 041. SOUTH AMERICA INFUSION PUMP MARKET, BY APPLICATION (2016-2030)
TABLE 042. SOUTH AMERICA INFUSION PUMP MARKET, BY END USER (2016-2030)
TABLE 043. INFUSION PUMP MARKET, BY COUNTRY (2016-2030)
TABLE 044. B. BRAUN MELSUNGEN AG (GERMANY): SNAPSHOT
TABLE 045. B. BRAUN MELSUNGEN AG (GERMANY): BUSINESS PERFORMANCE
TABLE 046. B. BRAUN MELSUNGEN AG (GERMANY): PRODUCT PORTFOLIO
TABLE 047. B. BRAUN MELSUNGEN AG (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. BECTON: SNAPSHOT
TABLE 048. BECTON: BUSINESS PERFORMANCE
TABLE 049. BECTON: PRODUCT PORTFOLIO
TABLE 050. BECTON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. DICKINSON: SNAPSHOT
TABLE 051. DICKINSON: BUSINESS PERFORMANCE
TABLE 052. DICKINSON: PRODUCT PORTFOLIO
TABLE 053. DICKINSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. & COMPANY (U.S.): SNAPSHOT
TABLE 054. & COMPANY (U.S.): BUSINESS PERFORMANCE
TABLE 055. & COMPANY (U.S.): PRODUCT PORTFOLIO
TABLE 056. & COMPANY (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. IRADIMED CORPORATION (U.S.): SNAPSHOT
TABLE 057. IRADIMED CORPORATION (U.S.): BUSINESS PERFORMANCE
TABLE 058. IRADIMED CORPORATION (U.S.): PRODUCT PORTFOLIO
TABLE 059. IRADIMED CORPORATION (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. BAXTER INTERNATIONAL INC. (U.S.): SNAPSHOT
TABLE 060. BAXTER INTERNATIONAL INC. (U.S.): BUSINESS PERFORMANCE
TABLE 061. BAXTER INTERNATIONAL INC. (U.S.): PRODUCT PORTFOLIO
TABLE 062. BAXTER INTERNATIONAL INC. (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. ICU MEDICAL INC. (U.S.): SNAPSHOT
TABLE 063. ICU MEDICAL INC. (U.S.): BUSINESS PERFORMANCE
TABLE 064. ICU MEDICAL INC. (U.S.): PRODUCT PORTFOLIO
TABLE 065. ICU MEDICAL INC. (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. TANDEM DIABETES CARE INC. (U.S.): SNAPSHOT
TABLE 066. TANDEM DIABETES CARE INC. (U.S.): BUSINESS PERFORMANCE
TABLE 067. TANDEM DIABETES CARE INC. (U.S.): PRODUCT PORTFOLIO
TABLE 068. TANDEM DIABETES CARE INC. (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. ICU MEDICAL INC. (U.S.): SNAPSHOT
TABLE 069. ICU MEDICAL INC. (U.S.): BUSINESS PERFORMANCE
TABLE 070. ICU MEDICAL INC. (U.S.): PRODUCT PORTFOLIO
TABLE 071. ICU MEDICAL INC. (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. MEDTRONIC (IRELAND): SNAPSHOT
TABLE 072. MEDTRONIC (IRELAND): BUSINESS PERFORMANCE
TABLE 073. MEDTRONIC (IRELAND): PRODUCT PORTFOLIO
TABLE 074. MEDTRONIC (IRELAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. SMITH MEDICAL (U.S.): SNAPSHOT
TABLE 075. SMITH MEDICAL (U.S.): BUSINESS PERFORMANCE
TABLE 076. SMITH MEDICAL (U.S.): PRODUCT PORTFOLIO
TABLE 077. SMITH MEDICAL (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. TERUMO CORPORATION (JAPAN): SNAPSHOT
TABLE 078. TERUMO CORPORATION (JAPAN): BUSINESS PERFORMANCE
TABLE 079. TERUMO CORPORATION (JAPAN): PRODUCT PORTFOLIO
TABLE 080. TERUMO CORPORATION (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND): SNAPSHOT
TABLE 081. F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND): BUSINESS PERFORMANCE
TABLE 082. F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND): PRODUCT PORTFOLIO
TABLE 083. F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. FRESENIUS SE & CO. KGAA (GERMANY): SNAPSHOT
TABLE 084. FRESENIUS SE & CO. KGAA (GERMANY): BUSINESS PERFORMANCE
TABLE 085. FRESENIUS SE & CO. KGAA (GERMANY): PRODUCT PORTFOLIO
TABLE 086. FRESENIUS SE & CO. KGAA (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. MINDRAY (INDIA): SNAPSHOT
TABLE 087. MINDRAY (INDIA): BUSINESS PERFORMANCE
TABLE 088. MINDRAY (INDIA): PRODUCT PORTFOLIO
TABLE 089. MINDRAY (INDIA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 090. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 091. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 092. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. INFUSION PUMP MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. INFUSION PUMP MARKET OVERVIEW BY TYPE
FIGURE 012. VOLUMETRIC INFUSION PUMPS MARKET OVERVIEW (2016-2030)
FIGURE 013. SYRINGE INFUSION PUMPS MARKET OVERVIEW (2016-2030)
FIGURE 014. PATIENT CONTROLLED ANALGESIA INFUSION PUMPS MARKET OVERVIEW (2016-2030)
FIGURE 015. INFUSION PUMP MARKET OVERVIEW BY APPLICATION
FIGURE 016. ONCOLOGY MARKET OVERVIEW (2016-2030)
FIGURE 017. PARENTERAL NUTRITION MARKET OVERVIEW (2016-2030)
FIGURE 018. PAIN MANAGEMENT MARKET OVERVIEW (2016-2030)
FIGURE 019. OTHERS MARKET OVERVIEW (2016-2030)
FIGURE 020. INFUSION PUMP MARKET OVERVIEW BY END USER
FIGURE 021. HOSPITALS & CLINICS MARKET OVERVIEW (2016-2030)
FIGURE 022. HOME HEALTHCARE MARKET OVERVIEW (2016-2030)
FIGURE 023. OTHERS MARKET OVERVIEW (2016-2030)
FIGURE 024. NORTH AMERICA INFUSION PUMP MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 025. EASTERN EUROPE INFUSION PUMP MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 026. WESTERN EUROPE INFUSION PUMP MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 027. ASIA PACIFIC INFUSION PUMP MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 028. MIDDLE EAST & AFRICA INFUSION PUMP MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 029. SOUTH AMERICA INFUSION PUMP MARKET OVERVIEW BY COUNTRY (2016-2030)